CORC

在结果中检索

CORC

浏览/检索结果: 共28条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer 期刊论文
2019, 卷号: 30, 期号: 8, 页码: 866-872
作者:  Luo Yang;  Li Wei;  Jiang Zefei;  Zhang Qingyuan;  Wang Liwei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial 期刊论文
2019, 卷号: 120, 页码: 20-30
作者:  Robson Mark;  Ruddy Kathryn J;  Im Seock-Ah;  Senkus Elżbieta;  Xu Binghe
收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Domchek, Susan M.;  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Li, Wei;  Im, Seock-Ah;  Xu, Binghe;  Robson, Mark;  Ouyang, Quchang
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe;  Masuda, Norikazu
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Domchek, Susan M.;  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Domchek, Susan M.;  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace